Fees in Respect of Dealer’s Licences Regulations
Version of section 25 from 2011-04-01 to 2020-03-31:
Marginal note:Drug analysis fee
25 In addition to the fees referred to in sections 19 to 22, if the application for an establishment licence seeks to authorize the holder to fabricate, package/label or import drugs or distribute drugs as a distributor referred to in paragraph C.01A.003(b) of the Food and Drug Regulations, the fee is the highest fee set out in column 2 of Schedule 5 that corresponds to the drugs described in column 1
(a) in respect of which the licence is requested; and
(b) for which the holder has obtained a drug identification number, except in the case of an importer.
- Date modified: